About GenScript
GenScript is a publicly listed company based in Piscataway (United States) founded in 2002. Reagents and instruments are provided for life sciences research. GenScript has raised $15 million across 1 funding round from investors including Kleiner Perkins. The company has 5,570 employees. GenScript has completed 1 acquisition, including CustomArray. Its chief executive, as recorded, is Frank Zhang. Its website genscript.com draws about 456 thousand monthly visits. Its focus areas include Life Sciences, Life Sciences Platforms and Tools, Research Reagents and Kits and Proteomics. Its competitors include Meridian Bioscience and Teknova.
Company details
GenScript was founded in 2002 and is headquartered in Piscataway, United States. Operations focus on the life sciences sector, where a range of services is offered, including bio-reagents, bio-assays, lead optimization, and antibody drug development. Emphasis is placed on CRISPR reagents for genome editing. Bioinformatics tools, such as those for molecular biology, peptides, and proteins, are also included in the portfolio.
- Headquarters Piscataway, United States
- Employees 5,570
- Stage Public
- SectorsHealthcare
- Website category Science and Education · Biology
- Website genscript.com
- Social LinkedIn X
- Legal Name Genscript Biotech Corporation
- Annual Revenue$960.92 M (USD)60.01as on Dec 31, 2025
- Net Profit-$533.13 M (USD)-96.93as on Dec 31, 2025
- EBITDA$330.16 M (USD)335.83as on Dec 31, 2025
- Total Equity Funding$15M (USD)
in 1 rounds
- Latest Funding Round$15M (USD), Series A
Jun 2009
- Investors
- Employee Count5,570
- Investments & Acquisitions
Funding Insights of GenScript
GenScript has successfully raised a total of $15M through 1 strategic funding round. The most recent funding activity was a Series A round of $15 million completed in June 2009. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $15M
- Total Rounds 1
- Last Round Series A — $15M
- First Round $15M
(Jun 2009)
- Investors Count 1
All 1 funding rounds of GenScript with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun 2009 | $15M | Series A | – | Kleiner Perkins | – |
1 investors in total: 1 institutional.
Investors in GenScript
GenScript has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Kleiner Perkins.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Venture capital firm investing in early-stage tech startups | 1972 | kleinerperkins.com | Menlo Park, United States |
Investor details for GenScript
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of GenScript
5 people are tracked at GenScript (2 in leadership, 3 in board & advisors); the tracked headcount is 5,570.
| Name | Role | Group |
|---|---|---|
Frank Zhang | CEO | Leadership |
Sherry Shao | Rotating CEO | Leadership |
George Church | Advisory Board Member | Board & advisors |
Carl June | Advisor | Board & advisors |
David Liu | Advisor | Board & advisors |
Complete people profiles for GenScript
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
IPO & Listings of GenScript
GenScript is a publicly listed company on the HKEX with ticker symbol 1548 in Hong Kong, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
- IPO date30 Dec 2015
- Listed onHKG: 1548
- Listed entityGenscript Biotech Corporation
- Exchange sectorHealth technology
- ISINKYG3825B1059
- Share price34.82 HKD (-2.08% on the day) · 2026-10-14
- Market capitalisation80,805,006,998.00 HKD
- EPS (diluted, trailing year)-2.29 HKD
- Volume (last session)42,889,083
Financials of GenScript
| Year | Revenue | Net income | EBITDA |
|---|---|---|---|
| 2025 | 7.48B HKD | -4.15B HKD | 2.57B HKD |
| 2024 | 4.68B HKD | -2.11B HKD | 589.0M HKD |
| 2023 | 4.37B HKD | -747.5M HKD | 616.0M HKD |
| 2022 | 4.90B HKD | -1.78B HKD | -2.90B HKD |
| 2021 | 3.81B HKD | -2.79B HKD | -2.50B HKD |
Detailed financial statements for GenScript
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Investments & Acquisitions by GenScript
GenScript has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include CustomArray.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Array-synthesized DNA capture probes are developed for targeted NGS sequencing. | customarrayinc.com | Redmond, United States | 2010 | Dec 2017 | •••• |
Complete acquisition details for GenScript
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of GenScript
4 dated milestones of GenScript across 15 years, from founding to its latest funding, stage changes and deals.
- Founded GenScript is founded.
- Funding First funding round of $15.0M.
- IPO Lists on the stock exchange (IPO).
- Acquisition Acquires CustomArray.
Competitors of GenScript
GenScript has 2 listed competitors in our database. They include Meridian Bioscience and Teknova.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| meridianbioscience.com | 1976 | Ohio, United States | Molecular diagnostic device and kits | |||
| teknova.com | 1996 | Hollister, United States | 290 | Molecular biology reagents and kits are supplied for research applications. |
Detailed competitors of GenScript
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of GenScript
The website of GenScript (genscript.com) receives about 456.1K visits a month and ranks #94,888 among all websites worldwide, #6,054 in Biology.
- Monthly visits456.1K
▼ 4.7% vs previous month
- Unique visitors167.3K
per month
- Global rank#94,888
among all websites
- Category rank#6,054
Science and Education · Biology
- Bounce rate44%
- Pages per visit3.7
- Average visit2 min 33 sec
- DevicesDesktop 55% · Mobile 45%
Websites whose visitors overlap most with GenScript. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| neb.com | 100% | 749.5K | #69,042 | View details | |
| abcam.com | 96% | 602.8K | #91,958 | View details | |
| sinobiological.com | 77% | 188.9K | #224,370 | View details | |
| ptglab.com | 76% | #137,673 | View details | ||
| clontech.com | 76% | View details | |||
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 40 similar websites and full traffic analytics for GenScript
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 40 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Genomics & Gene Therapy Platforms
3 companies that operate in the same segment as GenScript (Genomics & Gene Therapy Platforms) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Digital sequencing technology for cancer detection is developed. | 2012 | Redwood City, California, United States | USD 557.5 M | USD 982.02 M | 4,867 | |
Circulating tumor DNA is screened for early cancer detection. | 2016 | Menlo Park, California, United States | USD 2 B | USD 147.17 M | 1,141 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Genscript
Complete news archive for GenScript
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about GenScript
GenScript was founded in 2002 and raised its 1st funding round 7 years after it was founded.
GenScript is headquartered in Piscataway, United States. It is registered at Piscataway, New Jersey, United States.
Frank Zhang is the CEO of GenScript, as recorded in our data.
GenScript is a funded company, having raised a total of $15M across 1 funding round to date. The company's 1st funding round was a Series A of $15M, raised on Jun 2009.
GenScript has 5,570 employees.
Annual revenue of GenScript is $960.92M as on Dec 31, 2025.
GenScript was founded in 2002 and is headquartered in Piscataway, United States. Operations focus on the life sciences sector, where a range of services is offered, including bio-reagents, bio-assays, lead optimization, and antibody drug development. Emphasis is placed on CRISPR reagents for genome editing. Bioinformatics tools, such as those for molecular biology, peptides, and proteins, are also included in the portfolio.
GenScript's top competitors include Meridian Bioscience and Teknova.
Yes, GenScript is publicly traded on HKEX under the ticker symbol 1548.
GenScript has made 1 acquisition, including CustomArray.
GenScript has 1 investor. Key investors include Kleiner Perkins.
The website of GenScript receives about 456 thousand visits a month and ranks #94,888 among all websites worldwide.